Chapman Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.41M Buy
1,222
+522
+75% +$616K 0.93% 23
2026
Q2
$840K Hold
700
– – 0.56% 54
2026
Q1
$644K Buy
700
+10
+1% +$10.1K 0.46% 66
2025
Q4
$742K Hold
690
– – 0.51% 58
2025
Q3
$526K Buy
690
+436
+172% +$324K 0.36% 75
2025
Q2
$198K Buy
+254
New +$197K 0.17% 100
2024
Q4
$120K Buy
+156
New +$129K 0.1% 124

Other funds holding LLY

Chapman Financial Group's LLY Position: Q3 2026 in Review

Chapman Financial Group increased its Eli Lilly (LLY) stake by 75% in Q3 2026, buying an estimated $616K and bringing the position to 1,222 shares worth $1.41M. The position accounts for 0.93% of the portfolio, ranked #23.

Chapman Financial Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,741 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Chapman Financial Group held 1,222 shares of Eli Lilly worth $1.41M as of Q3 2026.
  • Chapman Financial Group bought 522 Eli Lilly shares in Q3 2026, an estimated $616K.
  • Eli Lilly made up 0.93% of Chapman Financial Group's portfolio in Q3 2026, its #23 holding.
  • Chapman Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,741 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Chapman Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.